COVID-19 patients who were previously vaccinated with Prevnar 13 and/or Pneumovax should have a lower risk of contracting (or dying from) secondary bacterial pneumonia.
Sure. I understand the urgency but this board is usually more rigorous and careful.
And I agree that in normal times, an abundance of caution is required. But these are NOT normal times and I don't think that you do grasp the urgency.
Is it not possible that ONE of the reasons that the Koreans have been so much more successful in dealing with this crisis is that they HAVE grasped the urgency and allowed for much more drug experimentation? Look, I respect Clark's knowledge of drug trials and biostatistics, but this is not the time for long, drawn out trials and biostatistic quibbling.
This is a clinical crisis. If we have something that shows overwhelming clinical success, albeit in a small sample size and without adequate controls (like double-blindedness), then it's incumbent on leaders like Fauci and Hahn to give their blessing. Sure, there are risks, but for people like me the only alternative is death.
You guys are talking about whether a fire extinguisher has been or should have been approved while the house is burning down. Just try it, guys, there are babies inside and the fire engines may not be here for years.
I think Fauci and Hahn and most of the medical establishment have been behind the curve on this from the very outset.
Jbog seems to be the only other person on this forum who gets it besides me and our politics are at opposite ends of the spectrum. LOL
I don't understand why Clark says that what NY is doing is not a set of clinical trial. What are they doing then? Do you not think that the medical researchers and doctors at the State Universities of NY, not to mention University of Rochester, University of Syracuse, Cornell/Weill, Albert Einstein, Mt. Sinai, Columbia, Memeorial Sloan Kettering know what their doing?